{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T01:43:17Z","timestamp":1785548597330,"version":"3.56.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council, Singapore","doi-asserted-by":"crossref","award":["NMRC\/Fellowship\/0045\/2017"],"award-info":[{"award-number":["NMRC\/Fellowship\/0045\/2017"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Health Innovation Centre, Singapore","award":["NHIC-I2D-1808207"],"award-info":[{"award-number":["NHIC-I2D-1808207"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s13346-021-00912-x","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T12:58:04Z","timestamp":1613048284000},"page":"7-14","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Liposomal drug delivery system for anti-inflammatory treatment after cataract surgery: a phase I\/II clinical trial"],"prefix":"10.1007","volume":"12","author":[{"given":"Chee Wai","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josbert M.","family":"Metselaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Storm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1429-2895","authenticated-orcid":false,"given":"Tina T.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,10]]},"reference":[{"issue":"10094","key":"912_CR1","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/S0140-6736(17)30544-5","volume":"390","author":"YC Liu","year":"2017","unstructured":"Liu YC, Wilkins M, Kim T, Malyugin B, Mehta JS. Cataracts Lancet. 2017;390(10094):600\u201312. https:\/\/doi.org\/10.1016\/S0140-6736(17)30544-5.","journal-title":"Cataracts. Lancet."},{"issue":"1","key":"912_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00055735-200002000-00002","volume":"11","author":"AZ McColgin","year":"2000","unstructured":"McColgin AZ, Heier JS. Control of intraocular inflammation associated with cataract surgery. Curr Opin Ophthalmol. 2000;11(1):3\u20136.","journal-title":"Curr Opin Ophthalmol"},{"issue":"6","key":"912_CR3","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/0039-6257(93)90141-S","volume":"37","author":"A Urtti","year":"1993","unstructured":"Urtti A, Salminen L. Minimizing systemic absorption of topically administered ophthalmic drugs. Surv Ophthalmol. 1993;37(6):435\u201356.","journal-title":"Surv Ophthalmol"},{"issue":"11","key":"912_CR4","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1185\/03007995.2013.833898","volume":"29","author":"GF Schwartz","year":"2013","unstructured":"Schwartz GF, Hollander DA, Williams JM. Evaluation of eye drop administration technique in patients with glaucoma or ocular hypertension. Curr Med Res Opin. 2013;29(11):1515\u201322. https:\/\/doi.org\/10.1185\/03007995.2013.833898.","journal-title":"Curr Med Res Opin."},{"issue":"11","key":"912_CR5","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/eye.2013.187","volume":"27","author":"AJ Tatham","year":"2013","unstructured":"Tatham AJ, Sarodia U, Gatrad F, Awan A. Eye drop instillation technique in patients with glaucoma. Eye (Lond). 2013;27(11):1293\u20138. https:\/\/doi.org\/10.1038\/eye.2013.187.","journal-title":"Eye (Lond)."},{"issue":"3","key":"912_CR6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.apsb.2016.09.001","volume":"7","author":"Y Weng","year":"2017","unstructured":"Weng Y, Liu J, Jin S, Guo W, Liang X, Hu Z. Nanotechnology-based strategies for treatment of ocular disease. Acta Pharm Sin B. 2017;7(3):281\u201391. https:\/\/doi.org\/10.1016\/j.apsb.2016.09.001.","journal-title":"Acta Pharm Sin B."},{"issue":"4","key":"912_CR7","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3109\/10717544.2014.943336","volume":"23","author":"R Agarwal","year":"2016","unstructured":"Agarwal R, Iezhitsa I, Agarwal P, et al. Liposomes in topical ophthalmic drug delivery: an update. Drug Deliv. 2016;23(4):1075\u201391. https:\/\/doi.org\/10.3109\/10717544.2014.943336.","journal-title":"Drug Deliv."},{"issue":"7","key":"912_CR8","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1002\/art.11140","volume":"48","author":"JM Metselaar","year":"2003","unstructured":"Metselaar JM, Wauben MH, Wagenaar-Hilbers JP, Boerman OC, Storm G. Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes. Arthritis Rheum. 2003;48(7):2059\u201366. https:\/\/doi.org\/10.1002\/art.11140.","journal-title":"Arthritis Rheum."},{"issue":"2","key":"912_CR9","doi-asserted-by":"publisher","first-page":"e54016","DOI":"10.1371\/journal.pone.0054016","volume":"8","author":"W Hofkens","year":"2013","unstructured":"Hofkens W, Schelbergen R, Storm G, van den Berg WB, van Lent PL. Liposomal targeting of prednisolone phosphate to synovial lining macrophages during experimental arthritis inhibits M1 activation but does not favor M2 differentiation. PLoS ONE. 2013;8(2):e54016. https:\/\/doi.org\/10.1371\/journal.pone.0054016.","journal-title":"PLoS ONE."},{"key":"912_CR10","unstructured":"Chang DF, Wong V. Two clinical trials of an intraocular steroid delivery system for cataract surgery. Trans Am Ophthalmol Soc. 1999;97:261\u201374; discussion 74\u20139"},{"issue":"6","key":"912_CR11","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.ophtha.2017.12.029","volume":"125","author":"E Donnenfeld","year":"2018","unstructured":"Donnenfeld E, Holland E. Dexamethasone intracameral drug-delivery suspension for inflammation associated with cataract surgery: a randomized, placebo-controlled. Phase III Trial Ophthalmology. 2018;125(6):799\u2013806. https:\/\/doi.org\/10.1016\/j.ophtha.2017.12.029.","journal-title":"Phase III Trial Ophthalmology."},{"issue":"10","key":"912_CR12","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.jcrs.2018.07.015","volume":"44","author":"ED Donnenfeld","year":"2018","unstructured":"Donnenfeld ED, Solomon KD, Matossian C. Safety of IBI-10090 for inflammation associated with cataract surgery: phase 3 multicenter study. J Cataract Refract Surg. 2018;44(10):1236\u201346. https:\/\/doi.org\/10.1016\/j.jcrs.2018.07.015.","journal-title":"J Cataract Refract Surg."},{"issue":"9","key":"912_CR13","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1089\/jop.2016.0025","volume":"32","author":"C Blizzard","year":"2016","unstructured":"Blizzard C, Desai A, Driscoll A. Pharmacokinetic studies of sustained-release depot of dexamethasone in beagle dogs. J Ocul Pharmacol Ther. 2016;32(9):595\u2013600. https:\/\/doi.org\/10.1089\/jop.2016.0025.","journal-title":"J Ocul Pharmacol Ther."},{"issue":"1","key":"912_CR14","doi-asserted-by":"publisher","first-page":"6604","DOI":"10.1038\/s41598-018-24545-2","volume":"8","author":"CW Wong","year":"2018","unstructured":"Wong CW, Czarny B, Metselaar JM, et al. Evaluation of subconjunctival liposomal steroids for the treatment of experimental uveitis. Sci Rep. 2018;8(1):6604. https:\/\/doi.org\/10.1038\/s41598-018-24545-2.","journal-title":"Sci Rep."},{"issue":"4","key":"912_CR15","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1021\/mp2000742","volume":"8","author":"JM van den Hoven","year":"2011","unstructured":"van den Hoven JM, Van Tomme SR, Metselaar JM, Nuijen B, Beijnen JH, Storm G. Liposomal drug formulations in the treatment of rheumatoid arthritis. Mol Pharm. 2011;8(4):1002\u201315. https:\/\/doi.org\/10.1021\/mp2000742.","journal-title":"Mol Pharm."},{"issue":"4","key":"912_CR16","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1136\/ard.2003.009944","volume":"63","author":"JM Metselaar","year":"2004","unstructured":"Metselaar JM, van den Berg WB, Holthuysen AE, Wauben MH, Storm G, van Lent PL. Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis. Ann Rheum Dis. 2004;63(4):348\u201353. https:\/\/doi.org\/10.1136\/ard.2003.009944.","journal-title":"Ann Rheum Dis."},{"issue":"5","key":"912_CR17","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.nano.2015.02.020","volume":"11","author":"ME Lobatto","year":"2015","unstructured":"Lobatto ME, Calcagno C, Otten MJ, et al. Pharmaceutical development and preclinical evaluation of a GMP-grade anti-inflammatory nanotherapy. Nanomedicine. 2015;11(5):1133\u201340. https:\/\/doi.org\/10.1016\/j.nano.2015.02.020.","journal-title":"Nanomedicine."},{"key":"912_CR18","doi-asserted-by":"publisher","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature Working G. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140(3):509\u201316.\u00a0https:\/\/doi.org\/10.1016\/j.ajo.2005.03.057.","DOI":"10.1016\/j.ajo.2005.03.057"},{"key":"912_CR19","doi-asserted-by":"publisher","unstructured":"Lorenz K, Dick B, Jehkul A, Auffahrt GU. Inflammatory response after phacoemulsification treated with 0.5% prednisolone acetate or vehicle. Graefes Arch Clin Exp Ophthalmol. 2008;246(11):1617\u20131622.\u00a0https:\/\/doi.org\/10.1007\/s00417-008-0908-2.","DOI":"10.1007\/s00417-008-0908-2"},{"key":"912_CR20","doi-asserted-by":"publisher","first-page":"548453","DOI":"10.1155\/2012\/548453","volume":"2012","author":"R Agrawal","year":"2012","unstructured":"Agrawal R, Murthy S, Ganesh SK, Phaik CS, Sangwan V, Biswas J. Cataract surgery in uveitis. Int J Inflam. 2012;2012:548453. https:\/\/doi.org\/10.1155\/2012\/548453.","journal-title":"Int J Inflam."},{"issue":"5","key":"912_CR21","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.ophtha.2006.08.053","volume":"114","author":"SJ Kim","year":"2007","unstructured":"Kim SJ, Equi R, Bressler NM. Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography. Ophthalmology. 2007;114(5):881\u20139. https:\/\/doi.org\/10.1016\/j.ophtha.2006.08.053.","journal-title":"Ophthalmology."},{"key":"912_CR22","doi-asserted-by":"publisher","first-page":"477","DOI":"10.2147\/OPTH.S98892","volume":"10","author":"JK Schmier","year":"2016","unstructured":"Schmier JK, Covert DW, Hulme-Lowe CK, Mullins A, Mahlis EM. Treatment costs of cystoid macular edema among patients following cataract surgery. Clin Ophthalmol. 2016;10:477\u201383. https:\/\/doi.org\/10.2147\/OPTH.S98892.","journal-title":"Clin Ophthalmol."},{"issue":"2","key":"912_CR23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0161-6420(99)90060-X","volume":"106","author":"DT Tan","year":"1999","unstructured":"Tan DT, Chee SP, Lim L, Lim AS. Randomized clinical trial of a new dexamethasone delivery system (Surodex) for treatment of post-cataract surgery inflammation. Ophthalmology. 1999;106(2):223\u201331. https:\/\/doi.org\/10.1016\/S0161-6420(99)90060-X.","journal-title":"Ophthalmology."},{"issue":"10","key":"912_CR24","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1016\/j.ophtha.2014.04.024","volume":"121","author":"DS Boyer","year":"2014","unstructured":"Boyer DS, Yoon YH, Belfort R Jr, et al. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology. 2014;121(10):1904\u201314. https:\/\/doi.org\/10.1016\/j.ophtha.2014.04.024.","journal-title":"Ophthalmology."},{"issue":"2","key":"912_CR25","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jcrs.2018.09.023","volume":"45","author":"SL Tyson","year":"2019","unstructured":"Tyson SL, Bafna S, Gira JP, et al. Multicenter randomized phase 3 study of a sustained-release intracanalicular dexamethasone insert for treatment of ocular inflammation and pain after cataract surgery. J Cataract Refract Surg. 2019;45(2):204\u201312. https:\/\/doi.org\/10.1016\/j.jcrs.2018.09.023.","journal-title":"J Cataract Refract Surg."},{"issue":"11","key":"912_CR26","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1136\/bjo.87.11.1424","volume":"87","author":"SY Lee","year":"2003","unstructured":"Lee SY, Chee SP, Balakrishnan V, Farzavandi S, Tan DT. Surodex in paediatric cataract surgery. Br J Ophthalmol. 2003;87(11):1424\u20136. https:\/\/doi.org\/10.1136\/bjo.87.11.1424.","journal-title":"Br J Ophthalmol."},{"issue":"12","key":"912_CR27","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1016\/S0161-6420(01)00839-9","volume":"108","author":"DT Tan","year":"2001","unstructured":"Tan DT, Chee SP, Lim L, Theng J, Van Ede M. Randomized clinical trial of Surodex steroid drug delivery system for cataract surgery: anterior versus posterior placement of two Surodex in the eye. Ophthalmology. 2001;108(12):2172\u201381.","journal-title":"Ophthalmology"},{"issue":"5","key":"912_CR28","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s10792-009-9310-2","volume":"30","author":"I Tugal-Tutkun","year":"2010","unstructured":"Tugal-Tutkun I, Herbort CP. Laser flare photometry: a noninvasive, objective, and quantitative method to measure intraocular inflammation. Int Ophthalmol. 2010;30(5):453\u201364. https:\/\/doi.org\/10.1007\/s10792-009-9310-2.","journal-title":"Int Ophthalmol."},{"key":"912_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2147\/OPTH.S237405","volume":"14","author":"M De Maria","year":"2020","unstructured":"De Maria M, Iannetta D, Cimino L, Coassin M, Fontana L. Measuring anterior chamber inflammation after cataract surgery: a review of the literature focusing on the correlation with cystoid macular edema. Clin Ophthalmol. 2020;14:41\u201352. https:\/\/doi.org\/10.2147\/OPTH.S237405.","journal-title":"Clin Ophthalmol."},{"issue":"9","key":"912_CR30","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/sj.eye.6701349","volume":"18","author":"Y Liu","year":"2004","unstructured":"Liu Y, Luo L, He M, Liu X. Disorders of the blood-aqueous barrier after phacoemulsification in diabetic patients. Eye (Lond). 2004;18(9):900\u20134. https:\/\/doi.org\/10.1038\/sj.eye.6701349.","journal-title":"Eye (Lond)."}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-021-00912-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-021-00912-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-021-00912-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T18:06:07Z","timestamp":1639677967000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-021-00912-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,10]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["912"],"URL":"https:\/\/doi.org\/10.1007\/s13346-021-00912-x","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,10]]},"assertion":[{"value":"15 January 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Chee Wai Wong: Novartis, Singapore (Honoraria), Bayer, Singapore (Honoraria), Roche, Singapore (Honoraria), IP and patent holder for liposomal prednisolone phosphate; Edmund Wong: None; Josbert M. Metselaar: Enceladus, Netherlands (CEO), IP and patent holder for liposomal prednisolone phosphate; Gert Storm: IP and patent holder for liposomal prednisolone phosphate; Tina T Wong: IP and patent holder for liposomal prednisolone phosphate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the SingHealth Centralised Institutional Review Board (protocol number R1600\/99\/2018).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Informed consent was obtained from all participants.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors give consent for publication.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}